|
|
IFN-λ: A new spotlight in innate immunity against influenza virus infection |
Yeping Sun, Jingwen Jiang, Po Tien, Wenjun Liu( ), Jing Li( ) |
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China |
|
|
|
Corresponding Author(s):
Wenjun Liu,Jing Li
|
Issue Date: 18 October 2018
|
|
1 |
Abboud G, Tahiliani V, Desai P, Varkoly K, Driver J, Hutchinson TE, Salek-Ardakani S (2015) Natural killer cells and innate interferon gamma participate in the host defense against respiratory vaccinia virus infection. J Virol 90:129–141
https://doi.org/10.1128/JVI.01894-15
|
2 |
Barr IG (2017) Assessing the potential pandemic risk of recent avian influenza viruses. Eur Respir J 49:1602517
https://doi.org/10.1183/13993003.02517-2016
|
3 |
Bauer TT, Ewig S, Rodloff AC, Muller EE (2006) Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis 43:748–756
https://doi.org/10.1086/506430
|
4 |
Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FHT, Gerlach T, Malinverni R, Moradpour Det al. (2013) IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J Exp Med 210:1109–1116
https://doi.org/10.1084/jem.20130012
|
5 |
Brandes M, Klauschen F, Kuchen S, Germain RN (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197–212
https://doi.org/10.1016/j.cell.2013.06.013
|
6 |
Broggi A, Tan Y, Granucci F, Zanoni I (2017) IFN-lambda suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol 18:1084–1093
https://doi.org/10.1038/ni.3821
|
7 |
Bui CM, Chughtai AA, Adam DC, MacIntyre CR (2017) An overview of the epidemiology and emergence of influenza A infection in humans over time. Arch Public Health 75:15
https://doi.org/10.1186/s13690-017-0182-z
|
8 |
Chai N, Swem LR, Park S, Nakamura G, Chiang N, Estevez A, Fong R, Kamen L, Kho E, Reichelt Met al. (2017) A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action. Nat Commun 8:14234
https://doi.org/10.1038/ncomms14234
|
9 |
Chow KT, Gale M Jr (2015) SnapShot: interferon signaling. Cell 163 (1808–1808):e1801
|
10 |
Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, Lafaille FG, Trouillet C, Schmolke M, Albrecht RAet al. (2015) Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348:448–453
https://doi.org/10.1126/science.aaa1578
|
11 |
Ciancanelli MJ, Abel L, Zhang SY, Casanova JL (2016) Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol 38:109–120
https://doi.org/10.1016/j.coi.2015.12.002
|
12 |
Dienz O, Rud JG, Eaton SM, Lanthier PA, Burg E, Drew A, Bunn J, Suratt BT, Haynes L, Rincon M (2012) Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol 5:258–266
https://doi.org/10.1038/mi.2012.2
|
13 |
Fineberg HV (2014) Pandemic preparedness and response—lessons from the H1N1 influenza of 2009. N Engl J Med 370:1335–1342
https://doi.org/10.1056/NEJMra1208802
|
14 |
Galani IE, Triantafyllia V, Eleminiadou EE, Koltsida O, Stavropoulos A, Manioudaki M, Thanos D, Doyle SE, Kotenko SV, Thanopoulou Ket al. (2017) Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity 46(875–890):e876
|
15 |
Galmozzi E, Vigano M, Lampertico P (2014) Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? Aliment Pharmacol Ther 39:569–578
https://doi.org/10.1111/apt.12631
|
16 |
Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L (2009) Detecting influenza epidemics using search engine query data. Nature 457:U1012–U1014
https://doi.org/10.1038/nature07634
|
17 |
Ivashkiv LB, Donlin LT (2014) Regulation of type I interferon responses. Nat Rev Immunol 14:36–49
https://doi.org/10.1038/nri3581
|
18 |
Iwasaki A, Pillai PS (2014) Innate immunity to influenza virus infection. Nat Rev Immunol 14:315–328
https://doi.org/10.1038/nri3665
|
19 |
Jiang JW, Li J, Fan WH, Zheng WN, Yu M, Chen C, Sun L, Bi YH, Ding C, Gao GFet al. (2016) Robust Lys63-linked ubiquitination of RIG-I promotes cytokine eruption in early influenza B virus infection. J Virol 90:6263–6275
https://doi.org/10.1128/JVI.00549-16
|
20 |
Lazear HM, Nice TJ, Diamond MS (2015) Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity 43:15–28
https://doi.org/10.1016/j.immuni.2015.07.001
|
21 |
Loo YM, Gale M Jr (2007) Influenza: fatal immunity and the 1918 virus. Nature 445:267–268
https://doi.org/10.1038/445267a
|
22 |
Ma W, Huang H, Chen J, Xu K, Dai Q, Yu H, Deng F, Qi X, Wang S, Hong Jet al. (2017) Predictors for fatal human infections with avian H7N9 influenza, evidence from four epidemic waves in Jiangsu Province, Eastern China, 2013–2016. Influenza Other Respir Viruses 11:418–424
https://doi.org/10.1111/irv.12461
|
23 |
Mendoza JL, Schneider WM, Hoffmann HH, Vercauteren K, Jude KM, Xiong A, Moraga I, Horton TM, Glenn JS, de Jong YPet al. (2017) The IFN-lambda-IFN-lambdaR1-IL-10Rbeta complex reveals structural features underlying type III IFN functional plasticity. Immunity 46:379–392
https://doi.org/10.1016/j.immuni.2017.02.017
|
24 |
Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, Diamond MS, Virgin HW (2015) Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347:269–273
https://doi.org/10.1126/science.1258100
|
25 |
Peiris JS, Cheung CY, Leung CY, Nicholls JM (2009) Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30:574–584
https://doi.org/10.1016/j.it.2009.09.004
|
26 |
Phillips S, Mistry S, Riva A, Cooksley H, Hadzhiolova-Lebeau T, Plavova S, Katzarov K, Simonova M, Zeuzem S, Woffendin Cet al. (2017) Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients. Front Immunol 8:621
https://doi.org/10.3389/fimmu.2017.00621
|
27 |
Poovorawan Y, Pyungporn S, Prachayangprecha S, Makkoch J (2013) Global alert to avian influenza virus infection: from H5N1 to H7N9. Pathog Glob Health 107:217–223
https://doi.org/10.1179/2047773213Y.0000000103
|
28 |
Ramsey C, Kumar A (2011) H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care 17:64–71
https://doi.org/10.1097/MCC.0b013e3283427259
|
29 |
Schneider WM, Chevillotte MD, Rice CM (2014) Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32:513–545
https://doi.org/10.1146/annurev-immunol-032713-120231
|
30 |
Short KR, Kroeze E, Fouchier RAM, Kuiken T (2014) Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 14:57–69
https://doi.org/10.1016/S1473-3099(13)70286-X
|
31 |
Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, Reading PC (2009) Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 183:7441–7450
https://doi.org/10.4049/jimmunol.0902497
|
32 |
Teijaro JR (2015) The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options. Curr Top Microbiol Immunol 386:3–22
https://doi.org/10.1007/82_2014_411
|
33 |
Zeuzem S, Arora S, Bacon B, Box T, Charlton M, Diago M, Dieterich D, Mur RE, Everson G, Fallon Met al. (2011) Pegylated interferon-Lambda (PEGIFN-lambda) shows superior viral response with improved safety and tolerability versus PEGIFN alpha-2A in HCV patients (G1/2/3/4): emerge phase IIB through week 12. J Hepatol 54:S538–S539
https://doi.org/10.1016/S0168-8278(11)61362-7
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|